M&A / Deals Amneal Agrees to Acquire Kashiv BioSciences for Total Payment up to $1.1 Billion Big Molecule WatchOn April 22, 2026 Amneal Pharmaceuticals, Inc.Read full story pharminent May 4, 2026 (Last updated: May 5, 2026) Big Molecule Watch On April 22, 2026 Amneal Pharmaceuticals, Inc. Read full story Please leave this field emptySign up to receive free daily digest Check your inbox or spam folder to confirm your subscription. Post navigation Previous: Part D Mail Order Prescription DrugsNext: Cytospire hauls in $83M for a new type of T cell engager Related Stories M&A / Deals J&J ventures further into in vivo CAR-T space with Sail partnership, potential buyout pharminent July 31, 2026 M&A / Deals Eisai and CORE Biomedicine agree on global licence for oncology pipeline pharminent July 29, 2026 M&A / Deals Argenx signs agreement to buy Forte Biosciences for $2.2bn pharminent July 28, 2026